BG Medicine, Inc.
BGMD
$0.00
$0.000.00%
OTC PK
| 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | |
|---|---|---|---|---|---|
| Net Income | -5.30M | -5.72M | -7.09M | -7.23M | -8.06M |
| Total Depreciation and Amortization | 87.00K | 100.00K | 116.00K | 127.00K | 131.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.57M | 1.65M | 1.58M | 913.00K | 893.00K |
| Change in Net Operating Assets | -24.00K | 350.00K | 10.00K | -986.00K | -1.13M |
| Cash from Operations | -3.67M | -3.62M | -5.39M | -7.18M | -8.17M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 13.00K | 13.00K | 13.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 13.00K | 13.00K | 13.00K | -- | -- |
| Total Debt Issued | 500.00K | 500.00K | 500.00K | -- | -- |
| Total Debt Repaid | -2.98M | -4.10M | -4.48M | -4.48M | -4.48M |
| Issuance of Common Stock | 2.50M | 2.50M | 0.00 | 9.26M | 9.26M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 2.00M | 2.00M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -960.00K | -960.00K | 0.00 | -243.00K | -243.00K |
| Cash from Financing | 1.06M | -64.00K | -3.98M | 4.54M | 4.54M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.60M | -3.67M | -9.36M | -2.64M | -3.63M |